Publications by authors named "Y Nash"

Claim this Profile
A
Antibody-Mediated Inhibition of Insulin-Degrading Enzyme Improves Insulin Activity in a Diabetic Mouse Model.
Ofir Fursht, Mirit Liran, Yuval Nash, Vijay Krishna Medala, Dor Ini

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Motor Symptoms of Amyotrophic Lateral Sclerosis: A Multi-Faceted Disorder.
Yuval Nash, Michal Sitty

J Neuromuscul Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From virus to diabetes therapy: Characterization of a specific insulin-degrading enzyme inhibitor for diabetes treatment.
Yuval Nash, Assaf Ganoth, Nofit Borenstein-Auerbach, Hilit Levy-Barazany, Guy Goldsmith

FASEB J· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-degrading enzyme higher in subjects with metabolic syndrome.
Y Sofer, Y Nash, E Osher, O Fursht, G Goldsmith

Endocrine· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha synuclein deficiency increases CD4 T-cells pro-inflammatory profile in a Nurr1-dependent manner.
Dorit Trudler, Hilit Levy-Barazany, Yuval Nash, Liron Samuel, Ronit Sharon

J Neurochem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis